Search

Displaying results 9971 - 9980 of 10000 in total
  1. Drug

    Atamestane

    go.drugbank.com/drugs/DB12194
    Investigational

    Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.

  2. Drug

    GSK-424887

    go.drugbank.com/drugs/DB12219
    Investigational

    Gsk424887 has been used in trials studying the basic science and treatment of Depressive Disorder and Anxiety Disorder.

  3. Drug

    MK-0777

    go.drugbank.com/drugs/DB12238
    Investigational

    MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.

  4. Drug

    CP-724714

    go.drugbank.com/drugs/DB12302
    Investigational

    CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.

  5. Drug

    Nepadutant

    go.drugbank.com/drugs/DB12538
    Investigational

    Nepadutant has been used in trials studying the treatment of Colic, Infantile Colic, and Infantile Functional Gastrointestinal Disorders.

  6. Drug

    Dianhydrogalactitol

    go.drugbank.com/drugs/DB12873
    Investigational

    Dianhydrogalactitol has been used in trials studying the treatment of GBM, Glioma, Glioblastoma, Brain Cancer, and Glioblastoma Multiforme.

  7. Drug

    Dihydrexidine

    go.drugbank.com/drugs/DB12890
    Investigational

    Dihydrexidine has been used in trials studying the treatment of SPD, Cocaine-Related Disorders, and Schizotypal Personality Disorder.

  8. Drug

    LY-2334737

    go.drugbank.com/drugs/DB12906
    Investigational

    LY2334737 has been used in trials studying the treatment of Solid Tumor, Metastatic Tumor, and Malignant Solid Tumor.

  9. Drug

    OPC1

    go.drugbank.com/drugs/DB17944
    Experimental

    OPC1 is an oligodendrocyte progenitor cell therapy being investigated for the treatment of acute spinal cord injury.[L47082]

  10. Drug

    NGN-101

    go.drugbank.com/drugs/DB18335
    Investigational

    NGN-101 is an adeno-associated virus serotype 9 vector with engineered transgene encoding the human CLN5 gene